Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Eur Respir J
.
2012 Apr;39(4):802-4.
doi: 10.1183/09031936.00171611.
Authors
A Zumla
,
F Blasi
,
M Raviglione
PMID:
22467721
DOI:
10.1183/09031936.00171611
No abstract available
Publication types
Editorial
MeSH terms
Antitubercular Agents / therapeutic use*
Communicable Disease Control / standards*
Communicable Disease Control / trends*
Drug Resistance, Bacterial*
European Union
Humans
Tuberculosis, Pulmonary / drug therapy*
Substances
Antitubercular Agents